Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 464
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Clinical Trials 93
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 88
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,381 Results (Page 45 of 120)
- Relevance
  Sort by

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1560 Pages
Global

From

€2195EUR$2,500USD£1,915GBP

Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1182 Pages
Global

From

€2195EUR$2,500USD£1,915GBP

Monoclonal Antibodies Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

 Report
July 2021
120 Pages
Global

From

€4170EUR$4,750USD£3,638GBP

Bile Duct Cancer Market 2024-2028

 Report
October 2024
136 Pages
Global

From

€2195EUR$2,500USD£1,915GBP

AI in Pharmaceutical Market - Global AI in Pharmaceutical Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030

 Report
August 2023
215 Pages
Global

€4209EUR$4,795USD£3,673GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

United Kingdom Pharmaceutical Market, By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2027

 Report
January 2023
73 Pages
United Kingdom

From

€3073EUR$3,500USD£2,681GBP

Biobetters - Global Strategic Business Report

 Report
February 2026
488 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

CTLA-4 Inhibitors for Cervical Cancer Market - Global Forecast 2026-2032

 Report
January 2026
192 Pages
Global

From

€3112EUR$3,545USD£2,715GBP

€3458EUR$3,939USD£3,017GBP

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
1814 Pages
Global

From

€1756EUR$2,000USD£1,532GBP

Mycosis Fungoides Therapeutics - Global Strategic Business Report

 Report
February 2026
182 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

Cough Remedy - Global Strategic Business Report

 Report
February 2026
383 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

Cough Remedies - Global Strategic Business Report

 Report
February 2026
274 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

Non-Hodgkin Lymphoma Therapeutics - Global Strategic Business Report

 Report
February 2026
192 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market - Global Strategic Business Report

 Report
February 2026
273 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

Lymphoma Therapeutics - Global Strategic Business Report

 Report
February 2026
406 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

B-Cell Lymphoma Treatment Market - Global Strategic Business Report

 Report
February 2026
392 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

Hodgkins Lymphoma Treatment - Global Strategic Business Report

 Report
February 2026
127 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

Digital Marketing Trends in Hepatocellular Carcinoma

 Report
September 2022
30 Pages
Global

From

€1712EUR$1,950USD£1,494GBP

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
232 Pages
Global

From

€1756EUR$2,000USD£1,532GBP

Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
628 Pages
Global

From

€2195EUR$2,500USD£1,915GBP

2,381 Results (Page 45 of 120)
- 1
- 43
- 44
- 45
- 46
- 47

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.